Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06482398

Cream Containing Sericin and Turmeric in Psoriasis Patients

Efficacy and Safety of Cream Containing Sericin and Turmeric in Psoriasis Patients

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Chulalongkorn University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Psoriasis lesion is divided into two parts. Half of the lesion will apply cream containing sericin and turmeric and another will apply steroid cream (control). The samples will be apply two times a day for 8 weeks. Psoriasis area and severity index, physician global assessment, body surface area of lesion, dermatology life quality index, Itching score, adverse reaction are evaluated before, after using the samples for 4 and 8 weeks.

Conditions

Interventions

TypeNameDescription
DRUGSericin extract and turmeric extract creamApply the sample 2 times a day for 8 weeks
DRUGTriamcinolone acetonide 1% CreamApply the sample 2 times a day for 8 weeks

Timeline

Start date
2024-07-01
Primary completion
2025-06-30
Completion
2025-07-31
First posted
2024-07-01
Last updated
2024-07-01

Source: ClinicalTrials.gov record NCT06482398. Inclusion in this directory is not an endorsement.